Skip to main content

FVP-P-264

Havrix 1440 Adult
Hepatitis A vaccine (inactivated)
Product Details
WHO Product ID
FVP-P-264
Status
Prequalified
Date of prequalification
Vaccine type
Hepatitis A vaccine (inactivated)
Abbreviated Name
HepA
Commercial Name
Havrix 1440 Adult
PQ Holder
GlaxoSmithKline Biologicals SA
20 Avenue Fleming 1300 Wavre Belgium
Wavre,
B-1300
Belgium
Responsible NRA
Federal Agency for Medicines and Health Products (FAMPH)
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
1
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 30
Multidose Vial Policy
Not applicable
Shelf life (months)
36 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
None
Product Packaging
Secondary Container
Tertiary Container
Shipping Container
Component Packed
Active (Vaccine)
Total doses
100
Description
Carton of 100 vials [Dimensions 17.8x14.7x3.7 cm]
Dimensions
17.8 x 14.7 x 3.7 cm
Cold Chain Volume (cm³/dose)
9.68
Component Packed
Active (Vaccine)
Total doses
100
Description
Carton of 25 vials [Dimensions 9.9x7.7x3.7] cm
Dimensions
9.9 x 7.7 x 3.7 cm
Cold Chain Volume (cm³/dose)
11.28
Component Packed
Active (Vaccine)
Total doses
100
Description
Carton of 10 vials [Dimensions 8.4x3.7x3.7
Dimensions
8.4 x 3.7 x 3.7 cm
Cold Chain Volume (cm³/dose)
11.5
Component Packed
Active (Vaccine)
Total doses
100
Description
d.Carton of 1 vial [Dimensions 3.1x3.1x 6.0 cm]
Dimensions
3.1 x 3.1 x 6.0 cm
Cold Chain Volume (cm³/dose)
57.66
Attachments
Package Insert-pq_267_268_HepA_GSK_PI-2023
VPSAR (Vaccine Public Summary Assessment Report)-pq_267_268_Havrix_HepA_GSK_VPASR